You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 167 No. 7, April 9, 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correction
 This Article
 •PDF of this Correction
 •Original article not online
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Error in Figure in: Outpatient Hypertension Treatment, Treatment Intensification, and Control in Western Europe and the United States

Arch Intern Med. 2007;167(7):648.

In the Original Investigation by Wang et al titled "Outpatient Hypertension Treatment, Treatment Intensification, and Control in Western Europe and the United States," published in the January 22 issue of the ARCHIVES (2007;167:141-147), an error occurred in Figure 1 on page 144. In that figure, the order of countries in the key, to coordinate with the shading of the bars from darkest to lightest, should have appeared as follows: France (n = 3009), Germany (n = 3178), Italy (n = 3316), Spain (n = 3704), United Kingdom (n = 2809), and United States (n = 3750). The corrected figure is reproduced here with its legend.


Figure 1
View larger version (39K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Figure 1. Cross-national differences in the use of 7 antihypertensive drug classes and combination drug therapy among treated hypertensive patients. ACE indicates angiotensin-converting enzyme; ARB, angiotensin II receptor blocker; and CCB, calcium channel blocker.








HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.